To uncover the mechanisms underlying the improvement in hepatic steatosis by a KD, we performed RNA-Seq analysis on mouse livers and found that the mRNA expression profile of Fgf21 signaling was significantly upregulated, especially Fgf21, Klb, and Fgfr1 (Fig. 3A). The gene discussed is FGFR1; the disease is fatty liver disease.